(Total Views: 307)
Posted On: 09/28/2020 10:19:54 AM
Post# of 36568
This then is open to interpretation:
100% funding for development, manufacturing and commercial registration of Ii-Key- SARS-CoV-2 prophylactic vaccine against COVID-19 in Malaysia
The development has to happen somewhere for it to get approved by the FDA.
100% funding for development, manufacturing and commercial registration of Ii-Key- SARS-CoV-2 prophylactic vaccine against COVID-19 in Malaysia
The development has to happen somewhere for it to get approved by the FDA.
(0)
(0)
